Search Results - "Payan, Christine A"
-
1
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
Published in The lancet. Diabetes & endocrinology (01-12-2013)“…Summary Background An improper balance of regulatory/effector T (Treg /Teff ) cells is central to the development of autoimmune diseases, including type 1…”
Get full text
Journal Article -
2
Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale
Published in PloS one (04-08-2011)“…The Natural History and Neuroprotection in Parkinson Plus Syndromes (NNIPPS) study was a large phase III randomized placebo-controlled trial of riluzole in…”
Get full text
Journal Article -
3
Rasch analysis of clinical outcome measures in spinal muscular atrophy
Published in Muscle & nerve (01-03-2014)“…ABSTRACT Introduction: Trial design for SMA depends on meaningful rating scales to assess outcomes. In this study Rasch methodology was applied to 9 motor…”
Get full text
Journal Article -
4
Development of a French Isometric Strength Normative Database for Adults Using Quantitative Muscle Testing
Published in Archives of physical medicine and rehabilitation (01-10-2007)“…Abstract Hogrel J-Y, Payan CA, Ollivier G, Tanant V, Attarian S, Couillandre A, Dupeyron A, Lacomblez L, Doppler V, Meininger V, Tranchant C, Pouget J,…”
Get full text
Journal Article -
5
Natural history of LGMD2A for delineating outcome measures in clinical trials
Published in Annals of clinical and translational neurology (01-04-2016)“…Objective Limb‐girdle muscular dystophy 2A (LGMD2A, OMIM) is a slowly progressive myopathy caused by the deficiency in calpain 3, a calcium‐dependent cysteine…”
Get full text
Journal Article -
6
Genome‐wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy
Published in Movement disorders (01-07-2019)“…Background Progressive supranuclear palsy is a neurodegenerative tauopathy manifesting clinically as a progressive akinetic‐rigid syndrome. In this study, we…”
Get full text
Journal Article -
7
A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability
Published in Journal of neurology, neurosurgery and psychiatry (01-09-2011)“…AimTo evaluate a standardised MRI acquisition protocol and a new image rating scale for disease severity in patients with progressive supranuclear palsy (PSP)…”
Get full text
Journal Article -
8
Natural history of LGMD 2A for delineating outcome measures in clinical trials
Published in Annals of clinical and translational neurology (01-04-2016)“…Abstract Objective Limb‐girdle muscular dystophy 2A ( LGMD 2A, OMIM ) is a slowly progressive myopathy caused by the deficiency in calpain 3, a…”
Get full text
Journal Article -
9
-
10
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
Published in Nature genetics (01-03-2022)“…Wouter van RheenenE), Rick A. A. van der Spek, Mark K. Bakker©, Joke J. F. A. van Vugt, Paul J. Hop, Ramona A. J. Zwamborn, Niek de Klein©, Harm-Jan WestraE),…”
Get full text
Journal Article